DALLAS , Sept 2, 2014 /PRNewswire/ -- Lennox International Inc. (NYSE: LII) today announced that CFO Joe Reitmeier is scheduled to present at the Vertical Research Partners 2014 Industrials Conference on Thursday, September 4 .
InterHealth Canada Ltd., a global healthcare management firm, and RGP
Healthcare™, a division of Resources Global Professionals (NASDAQ:
RECN), today jointly announced that InterHealth Canada plans to
implement Pavisse™, a cutting-edge electronic incident management
system, at its hospitals in the Turks and Caicos Islands (TCI Hospitals).
Pavisse will be deployed at both Cheshire Hall Medical Centre and
Cockburn Town Medical Centre to manage incidents across the entire
TSYS (NYSE: TSS) today announced that its board of directors has
approved a quarterly cash dividend of $0.10 per share on TSYS common
stock, payable October 1, 2014, to TSYS shareholders of record as of the
close of business on September 18, 2014.
Blackbaud, Inc. (Nasdaq: BLKB ),
a leading global provider of software and services for nonprofits, today
announced it has signed an agreement to acquire MicroEdge, LLC, an
innovative provider of mission-critical software solutions for the
philanthropic giving community worldwide .
American CareSource Holdings (NASDAQ: ANCI), operator of urgent care
centers and a national network of ancillary health care providers, today
announced that it has successfully completed its previously announced
acquisition of substantially all the assets of Bay Walk-In Clinic in
Panama City and Panama City Beach, Fla.
DODGEVILLE, WI --
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company
focused on the development and commercialization of innovative medicines
to address unmet medical needs in neurological and related central
nervous system disorders, today announced that the U.S. Food and Drug
Administration (FDA) has granted Breakthrough Therapy designation to
NUPLAZID™ (pimavanserin) for the treatment of Parkinson’s disease
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.